Skip to main content
Novartis
language-selector-globe
Choose Location
  • International
  • Americas
  • Asia Pacific
  • Europe
  • Middle East & Africa
Global | English
Novartis Foundation | English
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe
Choose Location
International Americas Asia Pacific Europe Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 
      • Board of Directors 
        • Giovanni Caforio 
        • Simon Moroney 
        • Ton Buechner 
        • Patrice Bula 
        • Elizabeth (Liz) Doherty 
        • Ana de Pro Gonzalo 
        • Bridgette Heller 
        • Daniel Hochstrasser 
        • Frans van Houten 
        • Elizabeth McNally 
        • John D. Young 
        • Charlotte Pamer-Wieser 
      • Executive Committee 
        • Vasant (Vas) Narasimhan 
        • Shreeram Aradhye 
        • Victor Bulto 
        • Aharon (Ronny) Gal 
        • Karen L. Hale 
        • Patrick Horber 
        • Harry Kirsch 
        • Rob Kowalski 
        • Steffen Lang 
        • Fiona Marshall 
        • Lutz Hegemann 
        • Kees Roks 
        • Michelle Weese 
      • Products 
      • Therapeutic areas 
        • Cardiovascular, renal and metabolic 
        • Immunology 
        • Neuroscience 
        • Oncology 
      • People and culture 
      • Inclusion 
        • Promoting inclusion 
        • Building belonging 
        • Parental leave 
      • Novartis Gene Therapies 
      • Manufacturing 
      • Quality 
        • Audit program 
        • Novartis quality management system (QMS) 
        • Product and patient safety training 
        • Regulatory inspections 
        • Product recalls 
        • Third-party suppliers 
      • Novartis and the European Union (EU) 
      • Awards and recognition 
      Mother and daughter cuddling on a bed in a kids room

      About

      Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.

    • Patients and caregivers 
      • Novartis commitment to patients and caregivers 
      • Diseases 
      • Patient organization funding 
      • Patients perspectives stories 
      Adult daughter talking to her senior parents on a bench in a park

      Patients and caregivers

      Information for patients and their caregivers including clinical trial recruiting, managed access programs, funding opportunities for patient organizations and side effects reporting.

    • Healthcare professionals 
      • Medical congresses and events 
        • ASCO Annual Meeting 
      • Products 
      • Novartis pipeline 
      • Managed access programs 
        • Zolgensma® Global Managed Access Program (gMAP) 
      • Novartis external funding 
      • Healthcare professional resources by country 
      • Investigator-initiated trials / studies 
      • Novartis medical information 
        • Submit medical enquiry 
      Doctor discussing illness with patient in an office

      Healthcare professionals

      Resources for physicians and other healthcare professionals including clinical trial recruiting, grant funding, congresses and country-level information.

    • Research and development 
      • Technology platforms 
      • Research disease areas 
        • Cardiovascular and metabolic disease research at Novartis 
        • DAx: exploratory disease research at Novartis 
        • Global Health disease area research at Novartis 
        • Immunology disease research at Novartis 
        • Neuroscience research at Novartis 
        • Oncology research at Novartis 
      • Novartis pipeline 
      • Research collaborations 
      • Collaborations 
      A female research scientist in a lab looking at a sample

      Research & development

      Discover how Novartis turns breakthrough science into transformative, high-value treatments.
       

    • ESG 
      • Access 
        • Creating sustainable business models 
        • Value-based pricing 
        • Sub-Saharan Africa 
        • Donations 
        • Novartis access principles 
        • Novartis oncology access 
        • Patents and licensing 
      • Environmental sustainability 
        • Climate 
        • Nature - Waste 
        • Nature - Water 
      • Ethics, risk and compliance 
        • Ethical behavior 
        • Compliance 
        • Human rights 
        • Learning and engagement 
        • Integrated risk assurance 
      • Global health 
        • Pandemic preparedness 
        • Avoidable blindness 
        • Chagas disease 
        • Leprosy 
        • Malaria 
        • Sickle cell disease (SCD) 
        • Novartis Foundation 
      • Inclusion 
      • ESG index 
      • Reporting and transparency hub 
        • ESG rating performance 
        • Targets 
        • Patient organization funding 
        • Payments to healthcare professionals 
        • Public policy 
        • A living wage 
        • A safe workplace 
        • Animal research 
      Family and friends having a party at home

      Environmental, social and governance

      Learn about our commitments to making a positive impact on the world by providing access to innovative medicines, protecting the environment, and upholding high ethical standards. Explore the Novartis in Society Integrated Report.

    • Investors 
      • Event calendar 
      • Financial data 
        • Novartis annual results 
        • Novartis quarterly results 
        • Novartis SEC filings 
        • Product sales 
        • Fixed-income securities 
        • Expected currency impact 
      • Share data and analysis 
        • Share monitor 
        • Dividend information 
        • Share ownership 
        • Share overview 
        • Return on investment calculator 
      • Shareholder information 
        • General Meetings 
        • American Depositary Receipts (ADR) 
        • Share buyback 
        • Frequently asked questions 
      • Company overview 
        • Corporate governance 
      • Reporting and transparency hub 
        • Reporting archive 
        • ESG rating performance 
        • Publications order form 
      • ESG 
      Business woman working on her laptop in a bright atmosphere

      Investors

      Updates and resources for investors including financial information, disclosures, events, share price, ESG and reporting.

    • News 
      • News archive  
      • Media library  
      • Stories 
      • Subscribe 
      • Events 
      Overhead view of a meeting room with people in the foreground and screens in the background

      News

      Information for journalists including media releases, statements, stories, multimedia resources and more.

    • Careers 
      • Career search 
      • Our business functions 
        • Careers in research and development 
        • Careers in operations 
        • Careers in commercial and sales 
        • Careers in global functions 
      • Why Novartis 
      • Career hub 
        • Temporary contracts 
      • Early careers 
        • Graduates 
        • Students 
        • US Biomedical Research internship programs 
        • Community exploration and learning lab (CELL) 
      Two business people

      Careers

      Novartis is hiring! Find open positions, learn more about our strategy and culture, and apply today.

    • Clinical trials 
    • Partnering 
    • Supplier portal 
    • Report side effects 
    • Contacts 
    Grandmother, mother and daughter smiling and laughing on a beach

    Home

    Working together, we can reimagine medicine to improve and extend people’s lives.

  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title Sort ascending
  • Site
  • Location
  • Division
  • Business
  • Functional Area
  • Date Posted
Job Title Sort ascending Site Location Division Business Functional Area Date Posted
QC Operational Scheduler (Wed - Sat AM) Morris Plains USA Operations Innovative Medicines Quality Apr 18, 2025
QC Operational Scheduler (Sun - Wed AM) Morris Plains USA Operations Innovative Medicines Quality Apr 18, 2025
QC Specialist II Targu Mures Romania Operations Universal Hierarchy Node Quality Apr 17, 2025
Site Quality Head Nuremberg (Novartis Business Services GmbH) Germany Operations Universal Hierarchy Node Quality Apr 17, 2025
QA MD Operations & Project Expert Schaftenau Austria Operations Innovative Medicines Quality Apr 16, 2025
QA Operations Specialist Indianapolis USA Operations Innovative Medicines Quality Apr 15, 2025
QC Technician Indianapolis USA Operations Innovative Medicines Quality Apr 15, 2025
QC Analyst IV Tuas South Avenue Singapore Operations Innovative Medicines Quality Apr 14, 2025
AS&T Expert (Analytical) Tuas South Avenue Singapore Operations Innovative Medicines Quality Apr 13, 2025
Specialist, GMP QA Oversight, QOP India Hyderabad (Office) India Operations Innovative Medicines Quality Apr 11, 2025
Senior Expert en Transfert et Validation Analytique (H/F) - CDD Huningue France Operations Universal Hierarchy Node Quality Apr 11, 2025
Technicien(ne) de Laboratoire - Transfert Analytique (H/F) - CDD Huningue France Operations Universal Hierarchy Node Quality Apr 11, 2025
Technicien Contrôle Qualité Support Echantillons (H/F) - CDD Huningue France Operations Innovative Medicines Quality Apr 11, 2025
QA Specialist QMS Support Mumbai (Head Office) India Operations Universal Hierarchy Node Quality Apr 10, 2025
Specialist kontrole kakovost / QC Specialist (m/ž/d), Mengeš Mengeš Slovenia Operations Innovative Medicines Quality Apr 10, 2025
Scientist, Analytical Science & Tech Durham USA Operations Innovative Medicines Quality Apr 10, 2025
QA Compliance Specialist Indianapolis USA Operations Innovative Medicines Quality Apr 10, 2025
Sr. QC Analytical Chemist Indianapolis USA Operations Innovative Medicines Quality Apr 07, 2025
Quality Control Head Saluggia Italy Operations Innovative Medicines Quality Apr 04, 2025
QC Specialist I - Analytical Tuas South Avenue Singapore Operations Innovative Medicines Quality Apr 04, 2025
Sterility Assurance Lead Durham USA Operations Innovative Medicines Quality Apr 02, 2025
Technicien Support Contrôle Qualité (H/F) - CDD Huningue France Operations Innovative Medicines Quality Apr 02, 2025
AS&T Expert Selangor Malaysia Operations Universal Hierarchy Node Quality Apr 01, 2025
Labortechniker / QC Analyst II (m/w/d), Tirol, Österreich Schaftenau Austria Operations Innovative Medicines Quality Apr 01, 2025
Specialist - Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Apr 01, 2025
QA Operations Specialist Baarle Nassau Netherlands Operations Innovative Medicines Quality Mar 24, 2025
AS&T Lead Tuas South Avenue Singapore Operations Innovative Medicines Quality Mar 24, 2025
QC Microbiologist Indianapolis USA Operations Innovative Medicines Quality Mar 24, 2025
Quality Control Technician Zaragoza Spain Operations Innovative Medicines Quality Mar 19, 2025
Associate Director External Service Provider Quality Assurance Dublin (NOCC) Ireland Development Innovative Medicines Quality Mar 17, 2025
Country Head of Quality (Japan) Toranomon (NPKK Head Office) Japan Operations Universal Hierarchy Node Quality Mar 12, 2025
Senior Global Auditor – Pharmacovigilance Barcelona Gran Vía Spain Operations Innovative Medicines Quality Mar 07, 2025
QA Specialist Morris Plains USA Operations Innovative Medicines Quality Mar 07, 2025
QC Analyst Targu Mures Romania Quality Mar 05, 2025
Vodja upravljanja kakovosti - operacije (m/ž/d) / QA Operations Lead (m/f/d) Ljubljana Slovenia Operations Innovative Medicines Quality Feb 11, 2025
QA Expert Morris Plains USA Operations Innovative Medicines Quality Feb 10, 2025
QA Associate Morris Plains USA Operations Innovative Medicines Quality Feb 07, 2025
R&D Quality Manager Hyderabad (Office) India Development Innovative Medicines Quality Feb 06, 2025
Specialist kontrole kakovosti (m/ž/d), Ljubljana Ljubljana Slovenia Operations Innovative Medicines Quality Feb 04, 2025
QA Manager St. Petersburg (City) Russian Fed. Operations Innovative Medicines Quality Jan 28, 2025
ATMP Quality Assurance Lead Barcelona Gran Vía Spain Operations Innovative Medicines Quality Jan 27, 2025
Lead, QA Operations Indianapolis USA Operations Innovative Medicines Quality Jan 24, 2025
QA Operations Specialist Indianapolis USA Operations Innovative Medicines Quality Jan 24, 2025
Development Quality Assurance Manager Shanghai (Shanghai) China Development Innovative Medicines Quality Jan 21, 2025
QC Analyst II Changping County (Beijing) China Operations Innovative Medicines Quality Jan 21, 2025
Sr. eCompliance Specialist Hyderabad (Office) India Operations Innovative Medicines Quality Jan 20, 2025
QC Specialist I - Biochemistry Tuas South Avenue Singapore Operations Innovative Medicines Quality Jan 15, 2025
eCompliance Manager Hyderabad (Office) India Operations Innovative Medicines Quality Jan 08, 2025
Sr. eCompliance Specialist Hyderabad (Office) India Operations Innovative Medicines Quality Jan 08, 2025
Specialist-Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Jan 05, 2025

Pagination

  • ‹ Previous page
  • 1
  • 2
  • 3
  • › Next page

Novartis

Working together
  • Patients and caregivers
  • Healthcare professionals
  • Researchers
  • Job seekers
  • Journalists
  • Investors
Topics
  • Q1 2025
  • Eurovision
  • Access
  • ESG
  • SpeakUp
Explore
  • Pipeline
  • Products
  • Clinical trials
  • Partnering
  • Events
Therapeutic areas
  • Cardiovascular, renal and metabolic
  • Immunology
  • Neuroscience
  • Oncology
Footer Bottom
© 2025 Novartis AG
  • Terms of use
  • Privacy
  • Cookie settings
  • Contacts
  • Locations
  • Site map
  • Open source
  • Web accessibility
Novartis Site Directory
This site is intended for a global audience